English
简体中文
Total: £ 56.28
2026-03-25 | Pages: 120 | Tables: 111
The global Drugs Produced by Fermentation Engineering market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Fermentation is a process used for cultivating micro-organisms or other or...
2026-03-25 | Pages: 134 | Tables: 133
The global Panax Ginseng Products market was valued at US$ 5000 million in 2025 and is anticipated to reach US$ 7036 million by 2032, at a CAGR of 5.0% from 2026 to 2032.Panax Ginseng Products refer to a diverse range of commodities derived from the ...
2026-03-24 | Pages: 113 | Tables: 113
The global Anti-SCD1 Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. T...
2026-03-24 | Pages: 113 | Tables: 109
The global Exemestane Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. T...
2026-03-24 | Pages: 112 | Tables: 115
The global Misoprostol Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-24 | Pages: 96 | Tables: 100
The global Acipimox Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. Th...
2026-03-24 | Pages: 101 | Tables: 107
The global Fully Liquid DTap-Hib-IPV Combination Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-03-24 | Pages: 92 | Tables: 103
The global DTap-Hib-IPV Combination Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-03-24 | Pages: 107 | Tables: 92
The global Fully Liquid Pentavalent Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-03-24 | Pages: 147 | Tables: 140
The global Brain and Central Nervous System Cancer Treatments market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into ...
2026-03-24 | Pages: 142 | Tables: 147
The global Blood Cancer Treatments market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsca...
2026-03-24 | Pages: 121 | Tables: 127
The global Cardiovascular and Cerebrovascular Disease Treatment Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertain...
2026-03-24 | Pages: 97 | Tables: 94
The global Meningitis Medication market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape...
2026-03-24 | Pages: 120 | Tables: 119
The global Gastric Mucosal Protective Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-03-24 | Pages: 97 | Tables: 99
The global Meningococcal Group A and C Conjugate Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
